Oncology

Patients who underwent gross total resection had a significantly increased 1-year survival rate.

Even in early clinical trials for cancer drugs, the use of precision medicine showed longer progression-free survival.

Patients in their 50s and 60s were more likely to be diagnosed with late stage lung cancer compared with older patients.

The absence of O-glycan sugars led to colitis and colon cancer in mouse models.

Mouse models of paclitaxel lower than clinical doses showed an increase of liver metastases.

Nanostructured lipid carriers filled with melatonin may boost chemotherapy efficacy.

Approximately 38% of women who had initial echocardiograms received a follow-up scan.

Women who undergo surgery for ovarian cancer lived four times longer than women who did not.

Restriction spectrum imaging distinguishes between different prostate cancer tumor grades.

Avella Specialty Pharmacy has distributed its fifth issue of Dispensing Excellence, a publication for healthcare providers, nurses, medical assistants and their patients.

Recent advances and updates in oncology and cancer drug development.

Eight genes expressed in glioblastoma tumors that can predict the survival time of the patient.

Robotic trainer rectum helps teach providers to better detect prostate cancer.

Hops could lower risk of breast cancer in post-menopausal women.

Patient navigators found to enhance adherence to screening guidelines in ethnic minority and less fortunate cancer patients.

Female mice with obese fathers have delayed development in breast tissue and higher rates of breast cancer.

Multiple myeloma cells show greater ability to spread in obese and morbidly obese patients.

Top news of the day from across the health care landscape.

Discovery may lead to new treatments for colon cancer.

Surgeons were able to remove 29% of additional tumors using OTL38.

Both patients with aggressive and non-aggressive ductal carcinoma in situ receive the same treatment.

Patients with increased PSA levels had a 71 to 86% higher risk of developing prostate cancer.

US cancer centers spent $173 million on advertising in 2014.

Avelumab is an experimental, full human anti-PD-L1 Ig G1 monoclonal antibody.

Mole rats are remarkably resistant to cancer.

UM-164 blocks the c-Src kinase that plays a role in the growth and spread of breast cancer.

Sutent is an oral multi-kinase inhibitor originally approved by the FDA in 2006.

Study finds disparities in cancer survival independent of socioeconomic status.